datamatters24/research-document-archive huggingface dataset:
I 
108TH CONGRESS 
2D SESSION 
H. R. 3856 
To limit the congressional redistricting that States may do after an 
apportionment. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004 
Mr. GREEN of Texas (for himself, Mr. LAMPSON, Ms. EDDIE BERNICE JOHN-
SON of Texas, Mr. REYES, Mr. STENHOLM, Ms. JACKSON-LEE of Texas, 
Mr. FROST, Mr. ORTIZ, Mr. SANDLIN, Mr. RODRIGUEZ, Mr. GONZALEZ, 
Mr. TURNER of Texas, Mr. EDWARDS, Mr. BELL, Mr. DOGGETT, and 
Mr. HINOJOSA) introduced the following bill; which was referred to the 
Committee on the Judiciary 
A BILL 
To limit the congressional redistricting that States may do 
after an apportionment. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Redistricting Integrity 
Act’’.
SEC. 2. LIMIT ON CONGRESSIONAL REDISTRICTING AFTER 
AN APPORTIONMENT. 
The Act entitled ‘‘An Act for the relief of Doctor Ri-
cardo Vallejo Samala and to provide for congressional re-
districting’’, approved December 14, 1967 (2 U.S.C. 2c), 
is amended by adding at the end the following: ‘‘A State 
which has been redistricted in the manner provided by law 
after an apportionment under section 22(a) of the Act en-
titled ‘An Act to provide for the fifteenth and subsequent 
decennial censuses and to provide for an apportionment 
of Representatives in Congress’, approved June 18, 1929 
(2 U.S.C. 2a), may not be redistricted again until after 
the next apportionment of Representatives under such sec-
tion, unless a Federal court requires the State to conduct 
such subsequent redistricting to comply with the Constitu-
tion or to enforce the Voting Rights Act of 1965 (42 
U.S.C. 1973 et seq.).’’. 
Æ
I 
108TH CONGRESS 
2D SESSION 
H. R. 3857 
To amend the Internal Revenue Code of 1986 to allow issuance of tax- 
exempt private activity bonds to finance certain surface transportation 
facilities. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004 
Mr. SAM JOHNSON of Texas (for himself, Mr. HERGER, Mr. NEAL of Massa-
chusetts, Mr. RAMSTAD, Mr. BRADY of Texas, Mr. HAYWORTH, Mr. 
SANDLIN, Mr. BURGESS, Mrs. MYRICK, Mr. SMITH of Texas, Mr. PAUL, 
Mr. SESSIONS, Mr. CULBERSON, Mr. BONILLA, and Mr. HALL) intro-
duced the following bill; which was referred to the Committee on Ways 
and Means 
A BILL 
To amend the Internal Revenue Code of 1986 to allow 
issuance of tax-exempt private activity bonds to finance 
certain surface transportation facilities. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Private Bonds for 
Modern Roads Act of 2004’’.
SEC. 2. TREATMENT OF BONDS FOR SURFACE TRANSPOR-
TATION FACILITIES AS EXEMPT FACILITY 
BONDS. 
(a) TREATMENT AS EXEMPT FACILITY BONDS.— 
Subsection (a) of section 142 of the Internal Revenue 
Code of 1986 (relating to exempt facility bond) is amend-
ed by striking ‘‘or’’ at the end of paragraph (12), by strik-
ing the period at the end of paragraph (13) and inserting 
‘‘, or’’, and by adding at the end the following new para-
graph: 
‘‘(14) surface transportation facilities.’’. 
(b) SURFACE TRANSPORTATION FACILITIES.—Sec-
tion 142 of such Code is amended by adding at the end 
the following new subsection: 
‘‘(l) SURFACE TRANSPORTATION FACILITIES.— 
‘‘(1) IN GENERAL.—For purposes of subsection 
(a)(14), the term ‘surface transportation facilities’ 
means highway facilities and surface freight transfer 
facilities. 
‘‘(2) HIGHWAY FACILITIES.—For purposes of 
this 
subsection, 
the 
term 
‘highway 
facilities’ 
means— 
‘‘(A) any surface transportation project eli-
gible for Federal assistance under title 23, 
United States Code (as in effect on the date of 
enactment of this subsection), and
‘‘(B) any project for an international 
bridge or tunnel for which an international enti-
ty authorized under Federal or State law is re-
sponsible. 
‘‘(3) SURFACE
FREIGHT
TRANSFER
FACILI-
TIES.—For purposes of this subsection, the term 
‘surface freight transfer facilities’ means any facility 
for the transfer of freight from truck to rail or rail 
to truck (including any temporary storage facility di-
rectly related to such transfer). 
‘‘(4) 
LIMITATION
ON
AGGREGATE
FACE 
AMOUNT OF TAX-EXEMPT FINANCING.— 
‘‘(A) IN GENERAL.—An issue shall not be 
treated as an issue described in subsection 
(a)(14) unless— 
‘‘(i) the Secretary of Transportation 
has allocated an amount to such issue 
under this paragraph, and 
‘‘(ii) the aggregate face amount of 
bonds issued pursuant to such issue does 
not exceed such amount. 
‘‘(B) 
ALLOCATION.—The 
Secretary 
of 
Transportation may allocate amounts to issues 
under this paragraph in such manner as the 
Secretary of Transportation determines appro-
108TH CONGRESS
2D SESSION
H. R. 3858
AN ACT
To amend the Public Health Service Act to increase the
supply of pancreatic islet cells for research, and to pro-
vide for better coordination of Federal efforts and infor-
mation on islet cell transplantation.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Pancreatic Islet Cell
Transplantation Act of 2004’’.
SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFI-
CATION.
Section 371 of the Public Health Service Act (42
U.S.C. 273) is amended by adding at the end the fol-
lowing:
‘‘(c) Pancreata procured by an organ procurement or-
ganization and used for islet cell transplantation or re-
search shall be counted for purposes of certification or re-
certification under subsection (b).’’.
SEC. 3. ANNUAL ASSESSMENT ON PANCREATIC ISLET CELL
TRANSPLANTATION.
Section 429 of the Public Health Service Act (42
U.S.C. 285c–3) is amended by adding at the end the fol-
lowing:
‘‘(d) In each annual report prepared by the Diabetes
Mellitus Interagency Coordinating Committee pursuant to
subsection (c), the Committee shall include an assessment
of the Federal activities and programs related to pan-
creatic islet cell transplantation. Such assessment shall,
at a minimum, address the following:
‘‘(1) The adequacy of Federal funding for tak-
ing advantage of scientific opportunities relating to
pancreatic islet cell transplantation.
‘‘(2) Current policies and regulations affecting
the supply of pancreata for islet cell transplantation.
‘‘(3) The effect of xenotransplantation on ad-
vancing pancreatic islet cell transplantation.
‘‘(4) The effect of United Network for Organ
Sharing policies regarding pancreas retrieval and
islet cell transplantation.
‘‘(5) The existing mechanisms to collect and co-
ordinate outcomes data from existing islet cell trans-
plantation trials.
‘‘(6) Implementation of multiagency clinical in-
vestigations of pancreatic islet cell transplantation.
‘‘(7) Recommendations for such legislation and
administrative actions as the Committee considers
appropriate to increase the supply of pancreata
available for islet cell transplantation.’’.
Passed the House of Representatives October 5,
2004.
Attest:
Clerk.
H. R. 3858
One Hundred Eighth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday,
the twentieth day of January, two thousand and four
An Act
To amend the Public Health Service Act to increase the supply of pancreatic islet
cells for research, and to provide for better coordination of Federal efforts and
information on islet cell transplantation.
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Pancreatic Islet Cell Transplan-
tation Act of 2004’’.
SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFICATION.
Section 371 of the Public Health Service Act (42 U.S.C. 273)
is amended by adding at the end the following:
‘‘(c) Pancreata procured by an organ procurement organization
and used for islet cell transplantation or research shall be counted
for purposes of certification or recertification under subsection (b).’’.
SEC. 
3. 
ANNUAL 
ASSESSMENT 
ON 
PANCREATIC 
ISLET 
CELL
TRANSPLANTATION.
Section 429 of the Public Health Service Act (42 U.S.C. 285c–
3) is amended by adding at the end the following:
‘‘(d) In each annual report prepared by the Diabetes Mellitus
Interagency Coordinating Committee pursuant to subsection (c),
the Committee shall include an assessment of the Federal activities
and programs related to pancreatic islet cell transplantation. Such
assessment shall, at a minimum, address the following:
‘‘(1) The adequacy of Federal funding for taking advantage
of scientific opportunities relating to pancreatic islet cell
transplantation.
‘‘(2) Current policies and regulations affecting the supply
of pancreata for islet cell transplantation.
‘‘(3) The effect of xenotransplantation on advancing pan-
creatic islet cell transplantation.
‘‘(4) The effect of United Network for Organ Sharing policies
regarding pancreas retrieval and islet cell transplantation.
‘‘(5) The existing mechanisms to collect and coordinate
outcomes data from existing islet cell transplantation trials.
‘‘(6) Implementation of multiagency clinical investigations
of pancreatic islet cell transplantation.
H. R. 3858—2
‘‘(7) Recommendations for such legislation and administra-
tive actions as the Committee considers appropriate to increase
the supply of pancreata available for islet cell transplantation.’’.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.
I 
108TH CONGRESS 
2D SESSION 
H. R. 3858 
To amend the Public Health Service Act to increase the supply of pancreatic 
islet cells for research, and to provide for better coordination of Federal 
efforts and information on islet cell transplantation. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004 
Mr. NETHERCUTT (for himself, Ms. DEGETTE, Mr. BASS, Mr. SCHIFF, Mr. 
FROST, Ms. BORDALLO, Mr. VAN HOLLEN, Mr. KLINE, Mr. GREEN of 
Texas, Mr. ANDREWS, Mr. WICKER, Mr. LANTOS, Mr. BECERRA, Mr. 
MOORE, Ms. DELAURO, Mr. MCHUGH, Mr. WELDON of Pennsylvania, 
and Mr. FOSSELLA) introduced the following bill; which was referred to 
the Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to increase the 
supply of pancreatic islet cells for research, and to pro-
vide for better coordination of Federal efforts and infor-
mation on islet cell transplantation. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Pancreatic Islet Cell 
Transplantation Act of 2004’’.
SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFI-
CATION. 
Section 371 of the Public Health Service Act (42 
U.S.C. 273) is amended by adding at the end the fol-
lowing: 
‘‘(c) Pancreata procured by an organ procurement or-
ganization and used for islet cell transplantation or re-
search shall be counted for purposes of certification or re-
certification under subsection (b).’’. 
SEC. 3. ANNUAL ASSESSMENT ON PANCREATIC ISLET CELL 
TRANSPLANTATION. 
Section 429 of the Public Health Service Act (42 
U.S.C. 285c–3) is amended by adding at the end the fol-
lowing: 
‘‘(d) In each annual report prepared by the Diabetes 
Mellitus Interagency Coordinating Committee pursuant to 
subsection (c), the Committee shall include an assessment 
of the Federal activities and programs related to pan-
creatic islet cell transplantation. Such assessment shall, 
at a minimum, address the following: 
‘‘(1) The adequacy of Federal funding for tak-
ing advantage of scientific opportunities relating to 
pancreatic islet cell transplantation. 
‘‘(2) Current policies and regulations affecting 
the supply of pancreata for islet cell transplantation.
‘‘(3) The effect of xenotransplantation on ad-
vancing pancreatic islet cell transplantation. 
‘‘(4) The effect of United Network for Organ 
Sharing policies regarding pancreas retrieval and 
islet cell transplantation. 
‘‘(5) The existing mechanisms to collect and co-
ordinate outcomes data from existing islet cell trans-
plantation trials. 
‘‘(6) Implementation of multiagency clinical in-
vestigations of pancreatic islet cell transplantation. 
‘‘(7) Recommendations for such legislation and 
administrative actions as the Committee considers 
appropriate to increase the supply of pancreata 
available for islet cell transplantation.’’. 
Æ
II 
108TH CONGRESS 
2D SESSION 
H. R. 3858 
IN THE SENATE OF THE UNITED STATES 
OCTOBER 6, 2004 
Received 
AN ACT 
To amend the Public Health Service Act to increase the 
supply of pancreatic islet cells for research, and to pro-
vide for better coordination of Federal efforts and infor-
mation on islet cell transplantation. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
HR 3858 RDS 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Pancreatic Islet Cell 
Transplantation Act of 2004’’. 
SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFI-
CATION. 
Section 371 of the Public Health Service Act (42 
U.S.C. 273) is amended by adding at the end the fol-
lowing: 
‘‘(c) Pancreata procured by an organ procurement or-
ganization and used for islet cell transplantation or re-
search shall be counted for purposes of certification or re-
certification under subsection (b).’’. 
SEC. 3. ANNUAL ASSESSMENT ON PANCREATIC ISLET CELL 
TRANSPLANTATION. 
Section 429 of the Public Health Service Act (42 
U.S.C. 285c–3) is amended by adding at the end the fol-
lowing: 
‘‘(d) In each annual report prepared by the Diabetes 
Mellitus Interagency Coordinating Committee pursuant to 
subsection (c), the Committee shall include an assessment 
of the Federal activities and programs related to pan-
creatic islet cell transplantation. Such assessment shall, 
at a minimum, address the following: 
‘‘(1) The adequacy of Federal funding for tak-
ing advantage of scientific opportunities relating to 
pancreatic islet cell transplantation.
HR 3858 RDS 
‘‘(2) Current policies and regulations affecting 
the supply of pancreata for islet cell transplantation. 
‘‘(3) The effect of xenotransplantation on ad-
vancing pancreatic islet cell transplantation. 
‘‘(4) The effect of United Network for Organ 
Sharing policies regarding pancreas retrieval and 
islet cell transplantation. 
‘‘(5) The existing mechanisms to collect and co-
ordinate outcomes data from existing islet cell trans-
plantation trials. 
‘‘(6) Implementation of multiagency clinical in-
vestigations of pancreatic islet cell transplantation. 
‘‘(7) Recommendations for such legislation and 
administrative actions as the Committee considers 
appropriate to increase the supply of pancreata 
available for islet cell transplantation.’’. 
Passed the House of Representatives October 5, 
2004. 
Attest: 
JEFF TRANDAHL, 
Clerk.
IB 
Union Calendar No. 446
108TH CONGRESS 
2D SESSION 
H. R. 3858
[Report No. 108–726] 
To amend the Public Health Service Act to increase the supply of pancreatic 
islet cells for research, and to provide for better coordination of Federal 
efforts and information on islet cell transplantation. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004
Mr. NETHERCUTT (for himself, Ms. DEGETTE, Mr. BASS, Mr. SCHIFF, Mr. 
FROST, Ms. BORDALLO, Mr. VAN HOLLEN, Mr. KLINE, Mr. GREEN of 
Texas, Mr. ANDREWS, Mr. WICKER, Mr. LANTOS, Mr. BECERRA, Mr. 
MOORE, Ms. DELAURO, Mr. MCHUGH, Mr. WELDON of Pennsylvania, 
and Mr. FOSSELLA) introduced the following bill; which was referred to 
the Committee on Energy and Commerce 
OCTOBER 5, 2004
Additional sponsors: Mr. DOGGETT, Ms. JACKSON-LEE
of Texas, Mr. 
RUPPERSBERGER, Mr. COSTELLO, Mr. ABERCROMBIE, Mr. TURNER of 
Texas, Mr. WAXMAN, Mr. MCDERMOTT, Mr. KILDEE, Mr. HINOJOSA, 
Mr. PALLONE, Mr. MEEHAN, Mr. MARKEY, Mr. QUINN, Mr. LAMPSON, 
Mrs. JO ANN DAVIS of Virginia, Mr. WOLF, Mr. WALSH, Ms. ROS-
LEHTINEN, Ms. SCHAKOWSKY, Mr. ACKERMAN, Mr. ROSS, Mr. HINCHEY, 
Mr. FOLEY, Mr. JENKINS, Mr. LEACH, Mr. HOLT, Mr. PASCRELL, Mrs. 
NAPOLITANO, Mr. MORAN of Virginia, Mr. VITTER, Ms. BERKLEY, Mr. 
CLAY, Mr. HILL, Mr. EMANUEL, Mr. CHABOT, Mr. HOEFFEL, Mr. BACH-
US, Mr. TIBERI, Mr. KENNEDY of Rhode Island, Mr. PAUL, Mr. MUR-
PHY, Mr. GOSS, Mr. GARRETT of New Jersey, Mr. MCGOVERN, Mr. 
SOUDER, Mr. GIBBONS, Mr. CASTLE, Mr. FRANK of Massachusetts, Ms. 
SLAUGHTER, Mr. PASTOR, Mr. SNYDER, Mr. LUCAS of Kentucky, Mr. 
RAMSTAD, Mr. SCOTT of Georgia, Mr. BISHOP of New York, Mr. 
BLUMENAUER, Mr. SABO, Mr. WELLER, Ms. SOLIS, Mr. GOODE, Mr. 
KIRK, Mr. TERRY, Mr. BOYD, Mr. KUCINICH, Mrs. BLACKBURN, Mr. 
TANCREDO, Mr. BACA, Mr. WEXLER, Mr. GORDON, Mr. SPRATT, Mr. 
COLE, Mr. HOEKSTRA, Mr. MCNULTY, Mr. SHUSTER, Mr. CULBERSON, 
Mr. 
FARR, 
Ms. 
MAJETTE, 
Mr. 
LARSEN
of 
Washington, 
Mr.
subsection (d)(1)) for cash contributions to a school 
tuition organization. 
‘‘(2) SCHOOL TUITION ORGANIZATION.—
‘‘(A) IN GENERAL.—The term ‘school tui-
tion organization’ means any organization de-
scribed in section 170(c)(2) if the annual dis-
bursements of the organization for elementary 
and secondary school scholarships are normally 
not less than 90 percent of the sum of such or-
ganization’s annual gross income and contribu-
tions and gifts. 
‘‘(B) 
ELEMENTARY
AND
SECONDARY 
SCHOOL SCHOLARSHIP.—The term ‘elementary 
and secondary school scholarship’ means any 
scholarship excludable from gross income under 
section 117 for expenses related to education at 
or below the 12th grade. 
‘‘(d) SPECIAL RULES.—
‘‘(1) DENIAL OF DOUBLE BENEFIT.—No deduc-
tion shall be allowed under this chapter for any con-
tribution for which credit is allowed under this sec-
tion. 
‘‘(2) APPLICATION
WITH
OTHER
CREDITS.—
The credit allowable under subsection (a) for any 
taxable year shall not exceed the excess (if any) of—
I 
#
108TH CONGRESS 
2D SESSION 
H. R. 3861
To amend part C of title XVIII of the Social Security Act to prohibit 
the operation of the Medicare comparative cost adjustment (CCA) pro-
gram in Texas. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004
Mr. RODRIGUEZ (for himself, Mr. SANDLIN, Mr. HINOJOSA, Mr. ORTIZ, Mr. 
FROST, Mr. TURNER of Texas, Mr. GREEN of Texas, Mr. BELL, Mr. 
DOGGETT, Mr. EDWARDS, Mr. REYES, Ms. JACKSON-LEE of Texas, and 
Mr. GONZALEZ) introduced the following bill; which was referred to the 
Committee on Energy and Commerce, and in addition to the Committee 
on Ways and Means, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall within 
the jurisdiction of the committee concerned 
A BILL 
To amend part C of title XVIII of the Social Security Act 
to prohibit the operation of the Medicare comparative 
cost adjustment (CCA) program in Texas.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
HR 3861 IH1S 
SECTION 1. PROHIBITION ON OPERATION OF MEDICARE 
COMPARATIVE 
COST 
ADJUSTMENT 
(CCA) 
PROGRAM IN TEXAS. 
Section 1860C–1(b)(2) of the Social Security Act (42 
U.S.C. 1395w–29(b)(2)), as added by section 241(a) of 
the Medicare Prescription Drug, Improvement, and Mod-
ernization Act of 2003 (Public Law 108–173), is amended 
by adding at the end the following new subparagraph: 
‘‘(C) NO PART IN TEXAS.—No part of the 
MSA is in Texas.’’.
Æ
I 
108TH CONGRESS 
2D SESSION 
H. R. 3862 
To provide an automatic pay increase to any member of the Armed Forces 
who is deployed away from the member’s permanent station or, in the 
case of a member of a reserve component of the Armed Forces, the 
member’s home of record, once the deployment period exceeds 180 days 
of continuous duty. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 26, 2004 
Mr. SCOTT of Virginia (for himself, Ms. NORTON, Mr. BISHOP of Utah, Mr. 
KENNEDY of Rhode Island, Mr. CROWLEY, Mr. ACEVEDO-VILA´, Mr. 
SCOTT of Georgia, Ms. DELAURO, Mr. RYAN of Ohio, Mr. TOWNS, Mr. 
JEFFERSON, Mr. STRICKLAND, Mrs. MALONEY, Mr. FROST, Mr. RAN-
GEL, Mr. MCGOVERN, Mr. STARK, Mr. WALSH, and Ms. WOOLSEY) in-
troduced the following bill; which was referred to the Committee on 
Armed Services 
A BILL 
To provide an automatic pay increase to any member of 
the Armed Forces who is deployed away from the mem-
ber’s permanent station or, in the case of a member 
of a reserve component of the Armed Forces, the mem-
ber’s home of record, once the deployment period exceeds 
180 days of continuous duty. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Extended Deployment 
Pay Increase Act of 2004’’. 
SEC. 2. PAY INCREASE FOR MEMBERS OF THE ARMED 
FORCES SERVING DEPLOYMENTS IN EXCESS 
OF 180 DAYS. 
(a) EXTENDED DEPLOYMENT PAY INCREASE.—A 
member of the Armed Forces who completes a period of 
180 days of continuous duty on deployment away from 
the permanent station of the member or, in the case of 
a member of a reserve component of the Armed Forces, 
the home of record of the member, is entitled to an in-
crease in the rate of basic pay in the amount of $1000 
for each month thereafter during which the member con-
tinues such deployment. Once a member has satisfied the 
continuous duty requirement with respect to a deployment, 
the member is not required to resatisfy the continuous 
duty requirement for the same deployment despite any 
break thereafter in the continuity of the deployment due 
to authorized leave or other absence. 
(b) RETROACTIVE APPLICATION.—Duty performed in 
connection with a deployment underway as of the date of 
the enactment of this Act, but commenced before such 
date, shall be counted toward the 180-day period specified 
in subsection (a). In the case of a member who completed 
the required period of continuous duty before the date of
the enactment of this Act, the entitlement to the increase 
in basic pay shall take effect on the first day of the first 
month beginning after the date of the enactment of this 
Act. 
Æ
(b) AUTHORITY
AND CRITERIA
FOR CLASSIFICA-
TION.—Section 201(g) of the Controlled Substances Act
(21 U.S.C. 811(g)) is amended—
(1) in paragraph (1), by striking ‘‘substance
from a schedule if such substance’’ and inserting
‘‘drug which contains a controlled substance from
the application of titles II and III of the Comprehen-
sive Drug Abuse Prevention and Control Act (21
U.S.C. 802 et seq.) if such drug’’; and
(2) in paragraph (3), by adding at the end the
following:
‘‘(C) Upon the recommendation of the Sec-
retary of Health and Human Services, a compound,
mixture, or preparation which contains any anabolic
steroid, which is intended for administration to a
human being or an animal, and which, because of its
concentration, preparation, formulation or delivery
system, does not present any significant potential for
abuse.’’.
(c) ANABOLIC STEROIDS CONTROL ACT.—Section
1903 of the Anabolic Steroids Control Act of 1990 (Public
Law 101–647; 21 U.S.C. 802 note) is amended—
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as
subsections (a) and (b), respectively.